Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SHARP PHILLIP A | Director | Feb 29 '24 | Option Exercise | 59.25 | 30,000 | 1,777,500 | 30,000 | Mar 01 04:12 PM | SHARP PHILLIP A | Director | Feb 29 '24 | Sale | 151.34 | 30,000 | 4,540,071 | 0 | Mar 01 04:12 PM | Greenstreet Yvonne | Chief Executive Officer | Feb 28 '24 | Sale | 155.31 | 2,932 | 455,357 | 48,128 | Feb 29 04:18 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Feb 28 '24 | Sale | 155.30 | 574 | 89,145 | 8,666 | Feb 29 04:17 PM | Poulton Jeffrey V. | EVP, Chief Financial Officer | Feb 28 '24 | Sale | 155.30 | 574 | 89,145 | 19,478 | Feb 29 04:18 PM | Tanguler Tolga | EVP, Chief Commercial Officer | Feb 28 '24 | Sale | 155.30 | 501 | 77,805 | 5,236 | Feb 29 04:18 PM | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 28 '24 | Sale | 155.30 | 329 | 51,094 | 4,133 | Feb 29 04:16 PM | Tanguler Tolga | EVP, Chief Commercial Officer | Feb 27 '24 | Option Exercise | 0.00 | 1,667 | 0 | 5,737 | Feb 29 04:18 PM | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 27 '24 | Option Exercise | 0.00 | 878 | 0 | 4,462 | Feb 29 04:16 PM | Greenstreet Yvonne | Chief Executive Officer | Feb 27 '24 | Option Exercise | 0.00 | 5,921 | 0 | 51,060 | Feb 29 04:18 PM | Poulton Jeffrey V. | EVP, Chief Financial Officer | Feb 27 '24 | Option Exercise | 0.00 | 1,908 | 0 | 20,052 | Feb 29 04:18 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Feb 27 '24 | Option Exercise | 0.00 | 1,908 | 0 | 9,240 | Feb 29 04:17 PM | Greenstreet Yvonne | Chief Executive Officer | Feb 16 '24 | Sale | 148.06 | 7,030 | 1,040,885 | 45,139 | Feb 20 04:07 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Feb 16 '24 | Sale | 148.06 | 1,308 | 193,666 | 7,332 | Feb 20 04:09 PM | Tanguler Tolga | EVP, Chief Commercial Officer | Feb 16 '24 | Sale | 148.06 | 1,009 | 149,397 | 4,070 | Feb 20 04:08 PM | Poulton Jeffrey V. | EVP, Chief Financial Officer | Feb 16 '24 | Sale | 148.06 | 1,007 | 149,099 | 18,144 | Feb 20 04:08 PM | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 02 '24 | Sale | 170.99 | 1,591 | 272,050 | 3,584 | Feb 05 04:05 PM | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 01 '24 | Option Exercise | 0.00 | 5,175 | 0 | 5,175 | Feb 05 04:05 PM | BONNEY MICHAEL W | Director | Dec 27 '23 | Option Exercise | 96.45 | 30,000 | 2,893,500 | 46,029 | Dec 29 04:03 PM | BONNEY MICHAEL W | Director | Dec 27 '23 | Sale | 195.00 | 30,000 | 5,850,000 | 16,029 | Dec 29 04:03 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Aug 07 '23 | Sale | 183.89 | 4,166 | 766,083 | 4,345 | Aug 07 06:05 PM | Vaishnaw Akshay | President | Aug 04 '23 | Sale | 185.85 | 4,057 | 753,986 | 22,774 | Aug 07 06:04 PM | Greenstreet Yvonne | Chief Executive Officer | Aug 04 '23 | Sale | 185.85 | 4,057 | 753,986 | 35,216 | Aug 07 06:04 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Aug 04 '23 | Sale | 185.85 | 3,461 | 643,223 | 8,511 | Aug 07 06:05 PM | Poulton Jeffrey V. | EVP, Chief Financial Officer | Aug 04 '23 | Sale | 185.85 | 3,460 | 643,037 | 15,873 | Aug 07 06:05 PM | BONNEY MICHAEL W | Director | Aug 03 '23 | Sale | 185.38 | 6,448 | 1,195,310 | 16,029 | Aug 04 04:02 PM | BONNEY MICHAEL W | Director | Aug 02 '23 | Option Exercise | 0.00 | 22,477 | 0 | 22,477 | Aug 04 04:02 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Apr 28 '23 | Sale | 199.02 | 2,455 | 488,595 | 4,345 | Apr 28 05:54 PM | Greenstreet Yvonne | Chief Executive Officer | Apr 27 '23 | Sale | 194.59 | 7,615 | 1,481,811 | 30,332 | Apr 28 05:55 PM | Vaishnaw Akshay | President | Apr 27 '23 | Sale | 194.59 | 2,392 | 465,464 | 17,890 | Apr 28 05:54 PM | Garg Pushkal | CMO & EVP Dev & Med Affairs | Apr 27 '23 | Sale | 194.59 | 1,839 | 357,855 | 6,800 | Apr 28 05:54 PM | Tanguler Tolga | EVP, Chief Commercial Officer | Apr 27 '23 | Sale | 194.59 | 1,476 | 287,215 | 1,801 | Apr 28 05:55 PM | Poulton Jeffrey V. | EVP, Chief Financial Officer | Apr 27 '23 | Sale | 194.59 | 977 | 190,113 | 11,706 | Apr 28 05:55 PM |
|